Venus Medtech (Hangzhou) Inc. (2500)’in fiyatı nedir?

Venus Medtech (Hangzhou) Inc. (2500)’in fiyatı $0.13048475’dir

Venus Medtech (Hangzhou) Inc. (2500)’in piyasa değeri nedir?

Venus Medtech (Hangzhou) Inc. (2500)’in piyasa değeri $57.55M’dir.

Venus Medtech (Hangzhou) Inc. (2500) Hisse Bölünmeleri

Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally. The company’s offers transcatheter aortic heart valve replacement products, such as VenusA-Valve, VenusA-Plus, VenusA-Pro, and VenusA-Deluxe; and VenusP-Valve, a transcatheter pulmonary valve system to treat the patients suffering with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract stenosis. It also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for the treatment of patients with mitral regurgitation and in pivotal clinical trial for the treatment of patients with tricuspid regurgitation; Liwen RF, a radiofrequency ablation system for the treatment of hypertrophic cardiomyopathy; and renal artery denervation ablation system for the treatment of hypertension. In addition, the company offers procedural accessories comprising catheter sheath product and balloon catheter. Venus Medtech (Hangzhou) Inc. was incorporated in 2009 and is headquartered in Hangzhou, the People’s Republic of China.

Yıl	Bölünme	Çarpan	Kümülatif Çarpan
Sağlanan tarihler için yeterli veri yok.

Yıl

Bölünme

Çarpan

Kümülatif Çarpan

Sağlanan tarihler için yeterli veri yok.

Şirket	Hisse bölünme sayısı	Kümülatif Çarpan	Ülke
STERIS plc STE.US	2	x4	IE
Shanghai United Imaging Healthcare Co., Ltd. 688271.SS	0	-	CN
Ypsomed Holding AG YPSN.SW	0	-	CH
Medacta Group S.A. MOVE.SW	0	-	CH
Jafron Biomedical Co.,Ltd. 300529.SZ	0	-	CN

Şirket

Hisse bölünme sayısı

Kümülatif Çarpan

Ülke